Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schwartsmann

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
CNS & Neurological Disorders Drug Targets|April 14, 2006
Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disordersR Roesler, J A P Henriques, G Schwartsmann
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2001
Intercellular contact-dependent survival of human A549, NCI-H596 and NCI-H520 non-small cell lung carcinoma cell linesM A Castro, G Schwartsmann, J C Moreira
Current Opinion in Pharmacology|November 17, 2001
Natural products in anticancer therapyA B da Rocha, R M Lopes, G Schwartsmann
The Oncologist|July 8, 2000
Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compoundsD R Mans, A B da Rocha, G Schwartsmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Successful treatment of AIDS-related Castleman's disease following the administration of highly active antiretroviral therapy (HAART)E Sprinz, M Jeffman, P Liedke, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell linesD R Mans, I Grivicich, G J Peters, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 22, 2001
Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancerI Grivicich, D R Mans, G J Peters, et al.
Cell Biology International Reports|September 1, 1987
Double-minute chromatin bodies in HL-60 leukemia cells sensitive and resistant to differentiation inducing agentsG Schwartsmann, K Madan, Y Heins, et al.
Journal of the National Cancer Institute|November 15, 1989
P-glycoprotein expression and AIDS-related Kaposi's sarcomaG Schwartsmann, C T Cerski, E Sander, et al.
The Lancet. Oncology|March 22, 2002
Marine organisms as a source of new anticancer agentsG Schwartsmann, A Brondani da Rocha, R G Berlinck, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
CNS & Neurological Disorders Drug Targets|April 14, 2006
Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disordersR Roesler, J A P Henriques, G Schwartsmann
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|July 27, 2001
Intercellular contact-dependent survival of human A549, NCI-H596 and NCI-H520 non-small cell lung carcinoma cell linesM A Castro, G Schwartsmann, J C Moreira
Current Opinion in Pharmacology|November 17, 2001
Natural products in anticancer therapyA B da Rocha, R M Lopes, G Schwartsmann
The Oncologist|July 8, 2000
Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compoundsD R Mans, A B da Rocha, G Schwartsmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Successful treatment of AIDS-related Castleman's disease following the administration of highly active antiretroviral therapy (HAART)E Sprinz, M Jeffman, P Liedke, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell linesD R Mans, I Grivicich, G J Peters, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 22, 2001
Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancerI Grivicich, D R Mans, G J Peters, et al.
Cell Biology International Reports|September 1, 1987
Double-minute chromatin bodies in HL-60 leukemia cells sensitive and resistant to differentiation inducing agentsG Schwartsmann, K Madan, Y Heins, et al.
Journal of the National Cancer Institute|November 15, 1989
P-glycoprotein expression and AIDS-related Kaposi's sarcomaG Schwartsmann, C T Cerski, E Sander, et al.
The Lancet. Oncology|March 22, 2002
Marine organisms as a source of new anticancer agentsG Schwartsmann, A Brondani da Rocha, R G Berlinck, et al.
Pageof 9